Daypro and Deep venous thrombosis - a phase IV clinical study of FDA data

Summary:

Deep venous thrombosis is reported as a side effect among people who take Daypro (oxaprozin), especially for people who are female, 60+ old, also take Vioxx, and have Arthritis.

The phase IV clinical study analyzes which people have Deep venous thrombosis when taking Daypro. It is created by eHealthMe based on reports of 2,818 people who have side effects when taking Daypro from the FDA, and is updated regularly.

What is Daypro?

Daypro has active ingredients of oxaprozin. It is often used in osteoarthritis. eHealthMe is studying from 2,883 Daypro users. Check the latest studies of Daypro.

What is Deep venous thrombosis?

Deep venous thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis) is found to be associated with 2,070 drugs and 2,962 conditions by eHealthMe. Check the latest studies of Deep venous thrombosis.

On Jul, 11, 2026

2,818 people reported to have side effects when taking Daypro.
Among them, 35 people (1.24%) have Deep venous thrombosis.

Could Daypro cause Deep venous thrombosis?

Among these 35 people:

What is the gender of people who have Deep venous thrombosis when taking Daypro? *

female: 91.43 %
male: 8.57 %

What is the age of people who have Deep venous thrombosis when taking Daypro? *

What are other drugs people take besides Daypro? *

What are other side effects people have besides Deep venous thrombosis? *

Stress And Anxiety: 22 people, 62.86%
Pulmonary Embolism (blockage of the main artery of the lung): 17 people, 48.57%
Fatigue (feeling of tiredness): 15 people, 42.86%
Heart Attack: 12 people, 34.29%
Oedema Peripheral (superficial swelling): 12 people, 34.29%
Lumbar Spinal Stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone): 12 people, 34.29%
Anaemia (lack of blood): 12 people, 34.29%
Cardiac Failure Congestive: 11 people, 31.43%
Injury: 10 people, 28.57%
High Blood Pressure: 10 people, 28.57%

What are the existing conditions these people have? *

Arthritis (form of joint disorder that involves inflammation of one or more joints): 10 people, 28.57%
Menopause (end of monthly cycles in women): 7 people, 20.00%
Acne (skin problems that cause pimples): 5 people, 14.29%
Constipation: 5 people, 14.29%
Breast Cancer: 4 people, 11.43%
Metastases To Bone (cancer spreads to bone): 4 people, 11.43%
Premenstrual Syndrome: 3 people, 8.57%
Hypersensitivity: 3 people, 8.57%
Heavy Or Prolong Menstrual Bleeding: 2 people, 5.71%
High Blood Pressure: 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Daypro and have Deep venous thrombosis?

- Check whether Deep venous thrombosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Daypro:

Daypro (2,883 reports)

Browse all side effects of Daypro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Deep venous thrombosis:

Deep venous thrombosis (2,070 drugs)

Browse all the conditions that are associated with Deep venous thrombosis:

Deep venous thrombosis (2,962 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxaprozin (the active ingredients of Daypro) and Daypro (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.